In the News

Constellation ShortList™ Virtual Care Platforms

Virtual healthcare technology has become the standard for healthcare because it enables better and more effective care. The most notable benefit of virtual care to patients is its convenience; rather than having to travel to and from a hospital or clinic to get or give care, patients can talk with their doctors or...

Propeller Health’s new deal with Orion Corporation extends its European reach

Wisconsin-based Propeller Health is partnering with Finnish pharmaceuticals and diagnostics company Orion Corporation to help European asthma and COPD sufferers. Starting in 2019, the companies will begin developing a custom-built Propeller sensor for Orion’s Easyhaler line of inhaled pulmonary drugs. These sensors...

Netsmart and American Well Partner to Address the Opioid Crisis at HIMSS19

Netsmart, a provider of electronic health records (EHR), solutions, and services to behavioral health, social services, and post-acute organizations, is partnering with American Well to provide a new approach to addressing the nation’s growing opioid crisis. The partnership was revealed as part of the...

Company that helps speed drug approvals raises $27 million

Manhattan-based health technology company Aetion has added $27 million to its previously announced Series B round, bringing the total raised in the round to $63 million and the company’s total funding to $77 million. The company attracted strategic investment from Sanofi, UCB, McKesson Ventures, and Horizon Health...

Global Health Leaders Back Aetion with $27 Million Strategic Investment

Aetion, a healthcare technology company that delivers the real-world analytics and evidence platform needed to engage in value-based care, announced that it has attracted strategic investment from global leaders in biopharma and healthcare services, including McKesson Ventures; Sanofi; UCB; and Horizon Health...

M&A Analysis: 10 Reasons Why ResMed Acquired Propeller Health for $225M

On December 3, ResMed announced that it was acquiring digital therapeutics manufacturer Propeller Health for $225 million. Part of ResMed’s goal in making this acquisition is to help establish itself as a leader in COPD management across all stages of the disease. ResMed is not only interested in augmenting its...